Jason A. Amello
Overview
Jason A. Amello received $692K in total compensation, including $466K in salary, at Candel Therapeutics in 2023. Jason Amello also received $753K at Akebia Therapeutics in 2014 and an average of $989K at ZIOPHARM Oncology between 2012 and 2013.
- 2023
- 2014
- 2013
- 2012
Candel TherapeuticsFormer Chief Financial Officer
Akebia TherapeuticsSenior Vice President, Chief Financial Officer and Treasurer
ZIOPHARM OncologyExecutive Vice President, Chief Financial Officer and Treasurer
ZIOPHARM OncologyExecutive Vice President, Chief Financial Officer and Treasurer
Source: SEC filings on May 30, 2024, April 30, 2015, and April 30, 2014.
Related executives
We found 18 more executives who work or worked at Candel Therapeutics, Akebia Therapeutics, andZIOPHARM Oncology.
Kevin Boyle
ZIOPHARM Oncology
Chief Executive Officer
Paul FMedSci
Candel Therapeutics
Chief Executive Officer
Francesca Barone
Candel Therapeutics
Chief Scientific Officer
Melinda Lackey
ZIOPHARM Oncology
SVP, Legal & Administration
Drew Deniger
ZIOPHARM Oncology
VP, Research and Development
Seshu RAC
Candel Therapeutics
Chief Technical and Development Officer
Estuardo inf
Candel Therapeutics
Chief Executive Officer
John Canepa
Candel Therapeutics